AI Breast Cancer Detection Tools Fall Short of Radiologists' Expectations
The Decoder · rss · 2026-08-13
A survey of 215 members of the Society of Breast Imaging reveals that while about half of radiologists already use FDA-approved AI tools for breast cancer detection, the actual performance falls short of expectations.
Only 35 percent of respondents reported lower recall rates, compared to the 59 percent who had anticipated such an improvement. The gap between promise and reality persists across every measured category.
More from Research
- AI Coding Benchmarks Under Fire: Secret Tests and Suspected Bias — astralmatrix · 2026-08-13
- Injecting Motion Understanding into Meta's Glimmer: The MotionGlimmer Project — andrew_n_carr · 2026-08-13
- HF Engineer Tests: Increasing Rollout Token Budget Improves Model Win Rate — mervenoyann · 2026-08-13
- Halluminate Introduces Westworld Finance Diligence Bench for AI Agents — ryanbed · 2026-08-13
- Deep Dive: Why Pretrained Weights Are Densely Surrounded by Task Experts — yacinelearning · 2026-08-13
- ARC-AGI-3 Text-Based Games Released: 21 Playable in Browser, API for Models — jcrwhittington · 2026-08-13